Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objectives. The number of metastatic lymph nodes (LNs) and the ratio between the number of metastatic LNs and the total number of retrieved LNs (the LN ratio [LNR]) have been proposed as risk factors for recurrence of papillary thyroid carcinoma (PTC). However, the significance of the number of LNs and the LNR in patients with clinically node negative PTC has not been clearly determined. The purpose of this study is to evaluate their significance. Methods. We retrospectively analyzed 382 patients with PTC who had undergone total thyroidectomy with prophylactic central neck dissection (CND) between January 2000 and December 2010. We excluded patients with lobectomy, concurrent lateral compartment neck dissection, a follow-up period less than at least 2 years, number of harvested central LNs less than or equal to one, clinically positive LN, distant metastasis, recurrent cancer or other types of malignancy. The correlations between recurrence and various clinicopathologic characteristics including tumor size, extrathyroidal extension (ETE), stage, number of metastatic central LNs, and the LNR were investigated. Results. After a mean follow-up period of 82.2±26.4 months, recurrence occurred in 14 patients (3.7%). Tumor size ≥20 mm, maximal ETE, presence of central LN metastasis, number of metastatic LNs ≥2, and LNR ≥0.31 correlated with recurrence in the univariate analysis. However, tumor size ≥20 mm, maximal ETE, number of metastatic LNs ≥2, and LNR ≥0.31 were significantly associated with recurrence in the multivariate analysis (hazard ratio=6.61, 7.17, 3.43, and 11.23, respectively). Conclusion. The LNR and the number of metastatic LNs are independent prognostic risk factors for recurrence in patients with clinically node negative PTC, and these factors can be used to guide postoperative adjuvant therapy and follow-up strategy after prophylactic CND.
Abstract
Objectives. The number of metastatic lymph nodes (LNs) and the ratio between the number of metastatic LNs and the total number of retrieved LNs (the LN ratio [LNR]) have been proposed as risk factors for recurrence of papillary thyroid carcinoma (PTC). However, the significance of the number of LNs and the LNR in patients with clinically node negative PTC has not been clearly determined. The purpose of this study is to evaluate their significance. Methods. We retrospectively analyzed 382 patients with PTC who had undergone total thyroidectomy with prophylactic central neck dissection (CND) between January 2000 and December 2010. We excluded patients with lobectomy, concurrent lateral compartment neck dissection, a follow-up period less than at least 2 years, number of harvested central LNs less than or equal to one, clinically positive LN, distant metastasis, recurrent cancer or other types of malignancy. The correlations between recurrence and various clinicopathologic characteristics including tumor size, extrathyroidal extension (ETE), stage, number of metastatic central LNs, and the LNR were investigated. Results. After a mean follow-up period of 82.2±26.4 months, recurrence occurred in 14 patients (3.7%). Tumor size ≥20 mm, maximal ETE, presence of central LN metastasis, number of metastatic LNs ≥2, and LNR ≥0.31 correlated with recurrence in the univariate analysis. However, tumor size ≥20 mm, maximal ETE, number of metastatic LNs ≥2, and LNR ≥0.31 were significantly associated with recurrence in the multivariate analysis (hazard ratio=6.61, 7.17, 3.43, and 11.23, respectively). Conclusion. The LNR and the number of metastatic LNs are independent prognostic risk factors for recurrence in patients with clinically node negative PTC, and these factors can be used to guide postoperative adjuvant therapy and follow-up strategy after prophylactic CND.
참고문헌 (30)
- Morris LG, "Changing trends in the incidence of thyroid cancer in the United States", JAMA Otolaryngol Head Neck Surg, 142(7), pp.709~711 (2016)[DOI]
- Brito JP, "Low risk papillary thyroid cancer", BMJ, 348, pp.g3045~ (2014)[DOI]
- Altekruse S, "Do US thyroid cancer incidence rates increase with socioeconomic status among people with health insurance? An observational study using SEER population-based data", BMJ Open, 5(12), pp.e009843~ (2015)[DOI]
- Grant CS, "Recurrence of papillary thyroid cancer after optimized surgery", Gland Surg, 4(1), pp.52~62 (2015)
- Liu FH, "Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis", J Surg Oncol, 112(2), pp.149~154 (2015)[DOI]
- Lan X, "A meta-analysis of central lymph node metastasis for predicting lateral involvement in papillary thyroid carcinoma", Otolaryngol Head Neck Surg, 153(5), pp.731~738 (2015)[DOI]
- Yan H, "A study on central lymph node metastasis in 543 cN0 papillary thyroid carcinoma patients", Int J Endocrinol, 2016, pp.1878194~ (2016)
- Chereau N, "Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: predictive factors and operative management", Surgery, 159(3), pp.755~762 (2016)[DOI]
- 박창호, "Significance of the Extracapsular Spread of Metastatic Lymph Nodes in Papillary Thyroid Carcinoma", Clinical and Experimental Otorhinolaryngology, 8(3), pp.289~294 (2015), 대한이비인후과학회[DOI]
- 지용배, "Postoperative Hypoparathyroidism and the Viability of the Parathyroid Glands During Thyroidectomy", Clinical and Experimental Otorhinolaryngology, 10(3), pp.265~271 (2017), 대한이비인후과학회[DOI]
- Ji YB, "Accuracy of intraoperative determination of central node metastasis by the surgeon in papillary thyroid carcinoma", Otolaryngol Head Neck Surg, 150(4), pp.542~547 (2014)[DOI]
- Podnos YD, "The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer", Am Surg, 71(9), pp.731~734 (2005)
- Zaydfudim V, "The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma", Surgery, 144(6), pp.1070~1077 (2008)[DOI]
- Sugitani I, "A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period", Surgery, 135(2), pp.139~148 (2004)[DOI]
- Park YM, "Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: a prognostic factor of locoregional recurrence", Head Neck, 38(Suppl 1), pp.E1172~E1176 (2016)[DOI]
- Vas Nunes JH, "Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma", Thyroid, 23(7), pp.811~816 (2013)[DOI]
- Schneider DF, "Lymph node ratio predicts recurrence in papillary thyroid cancer", Oncologist, 18(2), pp.157~162 (2013)[DOI]
- Jeon MJ, "The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma", Eur J Endocrinol, 168(2), pp.219~225 (2013)[DOI]
- Yip J, "Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence", Head Neck, 35(4), pp.592~598 (2013)[DOI]
- Schneider DF, "Impact of lymph node ratio on survival in papillary thyroid cancer", Ann Surg Oncol, 20(6), pp.1906~1911 (2013)[DOI]
- Ryu IS, "Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma", Ann Surg Oncol, 21(1), pp.277~283 (2014)[DOI]
- American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19(11), pp.1167~1214 (2009)[DOI]
- Viola D, "Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study", J Clin Endocrinol Metab, 100(4), pp.1316~1324 (2015)[DOI]
- Roh JL, "Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone", Ann Surg, 245(4), pp.604~610 (2007)[DOI]
- Shindo M, "The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer", Arch Otolaryngol Head Neck Surg, 132(6), pp.650~654 (2006)[DOI]
- Wang LY, "Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer", Thyroid, 24(12), pp.1790~1795 (2014)[DOI]
- 최성용, "Metastatic Lymph Node Ratio of Central Neck Compartment Has Predictive Values for Locoregional Recurrence in Papillary Thyroid Microcarcinoma", Clinical and Experimental Otorhinolaryngology, 9(1), pp.75~79 (2016), 대한이비인후과학회
- Lee SG, "Optimal cut-off values of lymph node ratio predicting recurrence in papillary thyroid cancer", Medicine (Baltimore), 95(5), pp.e2692~ (2016)[DOI]
- Beal SH, "An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma", Am Surg, 76(1), pp.28~32 (2010)
- Lee YC, "Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: a multi-institutional study", Surgery, 161(2), pp.465~471 (2017)[DOI]